UroGen Pharma Ltd.·4

Sep 8, 3:42 PM ET

Cohen Fred E 4

4 · UroGen Pharma Ltd. · Filed Sep 8, 2023

Insider Transaction Report

Form 4
Period: 2023-09-07
Cohen Fred E
Director
Transactions
  • Award

    Stock Option (right ot buy)

    2023-09-07+10,00010,000 total
    Exercise: $16.85Exp: 2033-09-07Ordinary Shares (10,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the stock option will vest in equal quarterly installments over a period of one year.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4